Cline successfully completes first stage of StemCART ex-vivo testing on human cartilage
Cline Scientific AB (“Cline” or “The Company”) has now completed the first stage related to the ex-vivo testing of its cartilage repair product, StemCART, on human cartilage tissue. Cline has carried out 12 implantation experiments with patient specimens according to the plan and protocol. Initial results show encouraging performance.The supporting matrix, which has been developed for use together with the cartilage cells, demonstrated the expected functionality in successfully fixing cells to the area of interest, which is one key aim of the ex-vivo testing. The ex-vivo tests continue